Company Profile
Profil emiten IDX — keuangan, direksi, komisaris, anak usaha
PT Pyridam Farma Tbk
PYFA
Sector: Healthcare
Industry: Pharmaceuticals
Sub Sector: Pharmaceuticals & Health Care Research
Sub Industry: Pharmaceuticals
PYFA
09:01
230
▲ +16 (+7.48%)
High 222
Low 0
Open —
Prev 214
TVol
3.719.800
Highlight Keuangan (2026 Q2) (In Rp)
EPS
-32
ROE
-52,11%
ROA
-4,82%
Book Value
61
Net Income
-178,28 M
Total Sales
1,62 T
Total Assets
7,39 T
DER
9.49x
Struktur Pemegang Saham (>1%)
Free Float Information
Saham tersebar di publik
24,76%
3,19%
Tentang Perusahaan
PT. Pyridam Farma Tbk. Founded in Jakarta based on Limited Company Act on November 27th 1976 and start the commercial operation since 1978 which conduct in pharmaceutical business.On its first establishmnent, the corporate produce & distribute medicine products for livestock & pet.. Since 1985 the corporate develop pharmacy division which emphasize produce and distribute health product for human and for livestock held by veterinary division.
Produk & Lini Bisnis
Currently, the Company's activities are engaged in the production and development of pharmaceutical products and trading of medical equipment as well.
Dewan Direksi
LY
Lee Yan Gwan
President Director
DW
dr. (Paulus ) Widjanarko Brotosaputro
Director
YG
Yenfrino Gunadi
Director
BS
Bedjo Stefanus
Director
Dewan Komisaris
RY
Robby Yulianto
President Commissioner
MS
Muhammad Syamsul Arifin
Independent Commissioner
ML
Maura Linda Sitanggang
Independent Commissioner
CD
Charles D. Marpaung
Independent Commissioner
Anak Usaha & Afiliasi
| Nama | Domisili | % |
|---|---|---|
| % |
Trend Keuangan (5 periode terakhir)
— hover bar untuk detail
Total Sales
Net Income (+)
Net Income (-)
2025 Q2
EPS -38
ROE -49,79%
2025 Q3
EPS -43
ROE -66,55%
2025 Q4
EPS -34
ROE -49,50%
2026 Q1
EPS -29
ROE -44,97%
2026 Q2
EPS -32
ROE -52,11%
Laporan Keuangan Historis (5 Periode Terakhir) (In Rp)
| Periode | Total Sales | Net Income | Total Assets | Total Equity | EPS | ROE | DER |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 1,62 T | -178,28 M | 7,39 T | 684,19 M | -32 | -52,11% | 9.49x |
| 2026 Q1 | 766,53 M | -80,88 M | 7,07 T | 719,41 M | -29 | -44,97% | 8.52x |
| 2025 Q4 | 2,76 T | -379,67 M | 6,77 T | 766,99 M | -34 | -49,50% | 7.54x |
| 2025 Q3 | 2,06 T | -365,82 M | 6,92 T | 732,88 M | -43 | -66,55% | 8.44x |
| 2025 Q2 | 1,39 T | -213,20 M | 6,85 T | 856,40 M | -38 | -49,79% | 7.00x |
History Harga Penutupan & Book Value
| Tahun | Qrt | Close Price (Rp) | Book Value (Rp) | ROA |
|---|---|---|---|---|
| 2026 | 2 | 174 | 61 | -4,82% |
| 2026 | 1 | 310 | 64 | -4,58% |
| 2025 | 4 | 476 | 68 | -5,61% |
| 2025 | 3 | 585 | 65 | -7,05% |
| 2025 | 2 | 238 | 76 | -6,22% |
Data diperbarui pada: 2026-05-12 11:44:30